A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Roche, Zealand shares fall on ‘undifferentiated’ obesity drug results
Roche, Zealand shares fall on ‘undifferentiated’ obesity drug results
Solid Biosciences gets $240M for pipeline; Roche expounds on lupus data
Solid Biosciences gets $240M for pipeline; Roche expounds on lupus data
Roche’s petrelintide shows promise in Phase II obesity trial - The Pharma Letter
Roche’s petrelintide shows promise in Phase II obesity trial - The Pharma Letter
Setting a new bar? Zealand touts 'placebo-like tolerability' for Roche-partnered weight loss drug
Setting a new bar? Zealand touts 'placebo-like tolerability' for Roche-partnered weight loss drug
Setting a new bar? Zealand touts 'placebo-like tolerability' for Roche-partnered weight loss drug - Fierce Biotech
Setting a new bar? Zealand touts 'placebo-like tolerability' for Roche-partnered weight loss drug - Fierce Biotech
Roche partner Zealand posts Phase 2 data for amylin obesity drug
Roche partner Zealand posts Phase 2 data for amylin obesity drug
Roche, Element and Ultima push toward the $100 genome
Roche, Element and Ultima push toward the $100 genome
Roche, stakeholders urge Africa to treat health as economic investment - Realnews Magazine
Roche, stakeholders urge Africa to treat health as economic investment - Realnews Magazine
Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem'
Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem'
Roche announces $481m investment in South Korean biotech sector - Investment Monitor
Roche announces $481m investment in South Korean biotech sector - Investment Monitor
Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem' - Fierce Biotech
Roche pumps $480M into South Korea biopharma industry to establish global trial 'ecosystem' - Fierce Biotech
Roche to invest $478 million in Korea clinical trials over 5 years - koreabiomed.com
Roche to invest $478 million in Korea clinical trials over 5 years - koreabiomed.com
Roche to invest $481 mn in South Korea clinical trials, biotech partnerships - The Korea Economic Daily Global Edition
Roche to invest $481 mn in South Korea clinical trials, biotech partnerships - The Korea Economic Daily Global Edition
Roche: Sustainable Operations, Supply Chains & AI in Health - Sustainability Magazine
Roche: Sustainable Operations, Supply Chains & AI in Health - Sustainability Magazine
Roche pill succeeds in another MS study, but approval questions linger
Roche pill succeeds in another MS study, but approval questions linger
Roche gets third pivotal win with MS drug, but liver signal could be a problem
Roche gets third pivotal win with MS drug, but liver signal could be a problem
Roche reports another phase 3 multiple sclerosis win, but deaths add to safety questions
Roche reports another phase 3 multiple sclerosis win, but deaths add to safety questions
Roche reports pivotal MS win, but deaths add to safety questions - Fierce Biotech
Roche reports pivotal MS win, but deaths add to safety questions - Fierce Biotech
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page